In order to assess the systemic prognosis of children with leukaemic ocular involvement, 63 of 131 patients admitted to hospital with acute leukaemia were evaluated ophthalmically. A total of 28 of 63 showed ophthalmic involvement and were followed up for up to 84 months. 
Though numerous studies'`8 have shown ocular involvement in leukaemia very few have suggested a relationship between the ocular findings and systemic prognosis.IIII10 In the era before antileukaemic therapy retinopathy was believed to be of no prognostic significance in acute leukaemia.'2 Since modern chemotherapy was introduced, it has prolonged the survival period and provided a possibility of cure in acute leukaemic children. Modern chemotherapy, however, has paradoxically increased the incidence of leukaemic cell infiltration especially to the central nervous system. There have been no studies, however, showing a correlation between ophthalmic findings in leukaemia and the systemic course of leukaemia in patients treated with chemotherapy. In this study we investigated the prognosis of patients with ophthalmic findings to see if they played a role in predicting the prognosis of leukaemia.
Materials and methods
From January 1972 to June 1987, 131 children with acute leukaemia were treated and followed at the St Luke's International Hospital (Tokyo) and Juntendo University Hospital. Sixty three of the 131 patients were referred to the department of ophthalmology by paediatricians. Forty seven were referred when signs or symptoms of ocular abnormalities were present and 16 were referred as having risk factors such as central nervous system leukaemia, severe thrombocytopenia, or marked leucocytosis. Twenty eight patients (14 male), showed leukaemic ophthalmic involvement at some point during the course of their disease. Six patients showed ophthalmic involvement at the onset of leukaemia and 22 at the time of either bone marrow or central nervous system relapse. Four patients had isolated ocular leukaemic relapse. The observation period for the 131 children was more than 5 years from the onset of disease for those children who survived. Eighty seven had acute lymphoblastic leukaemia, and 44 had acute nonlymphoblastic leukaemia. In the 28 patients with ophthalmic manifestations, 17 had acute lymphoblastic leukaemia, and 11 had acute nonlymphoblastic leukaemia. The age of the patients ranged from 3 months to 12 years with an average of 6-9 years. The diagnosis of the ophthalmic involvement was made after examination with both direct and indirect ophthalmoscopy and slit-lamp examination.
Among the referred cases 19 patients who had ocular abnormalities which were not directly linked to leukaemia such as infection, side effects of chemotherapy, and/or refractive errors, were excluded. One patient with retinal haemorrhage during remission was excluded because it was felt that a liver disorder was the main cause of the haemorrhage. Two patients with subconjunctival haemorrhage which occurred during remission were also excluded. All patients were treated, according to the protocol ofthe Tokyo Children's Leukemia Study Group, with multiple chemotherapeutic drugs and in some instances prophylactic irradiation for central nervous system leukaemia. None of the patients had bone marrow transplantation; no patients refused treatment; no patient died from causes other than complications of leukaemia.
In this study, onset of disease was defined as the earliest time that either symptoms or signs were noted; this applied to the underlying leukaemia and to ophthalmic manifestations.
Results
We classified ophthalmic involvements into two major categories: (1) direct leukaemic infiltration (23 cases), and (2) retinal haemorrhages and other vascular changes (13 cases). With direct leukaemic infiltration, four patterns occurred; optic nerve infiltration (five cases), anterior segment uveal infiltration (four cases), orbital infiltration (three cases), and neuro-ophthalmic sign of central nervous system leukaemia (16 cases), which included cranial nerve palsy and papilloedema. The retinal haemorrhages and other vascular changes were the results of haematological disorders. These included retinal or vitreous haemorrhage (11 cases), cotton wool spot (three cases), and tortuous vessels (one case). In the present study, bilateral disc oedema with increased intracranial pressure and no evidence ofleukaemic cell infiltration was defined as a neuro-ophthalmic sign of central nervous system leukaemia. Unilateral swelling of the optic nerve head without evidence of elevated intracranial pressure was defined as retrolaminar optic nerve infiltration. The numbers of patients with each type of leukaemia are shown in Table  1 . Eleven patients had more than two ophthalmic abnormalities. Direct leukaemic infiltration was treated by systemic chemotherapy and in some instances with intrathecal antileukaemic agents. Irradiation therapy specific to the eye was performed in six patients with leukaemic ophthalmic infiltration. Two patients who had optic nerve infiltration could not receive complete radiation therapy; one patient died during treatment, and the other showed leucoencephalopathy, a side effect of radiation therapy. Among 28 patients with ophthalmic manifestations, 23 (82 1%) experienced central nervous system leukaemia. All of the patients with ophthalmic manifestations experienced either central nervous system leukaemia or bone marrow relapse during the entire course of leukaemia.
Twenty seven (96-4%) of 28 patients died within 28 months from the onset of ophthalmic manifestations and within 83 months from the onset of leukaemia. The survival periods ranged from 15 days to 31 months after the onset of ophthalmic manifestation of leukaemia.
The 5 year survival rate for the 28 patients was 6/28 (21 4%). This was significantly lower than the rate for those who lacked ocular manifestations (16/35, 45-7% p<005).
Four of five patients with optic nerve infiltration, died within 22 months and one patient who had moderate optic disc swelling without the evidence of nerve head infiltration is still alive more than 31 months after the onset of ocular involvement ( Table 2 ). The survival periods from the onset of leukaemia ranged from 32 to more than 84 months. The average survival period was 508 months. All of the patients with anterior segment uveal infiltration died within 19 months from the onset of leukaemia (Table 3 ). The average survival periods were 8 5 months from the onset of ocular manifestation, and 16-0 months from the onset of leukaemia.
All the patients with orbital infiltration died within 15 months from the onset of leukaemia ( Table 4 ). The average survival period of the patients was 18 0 months.
In 16 patients with neuro-ophthalmic signs of central nervous system leukaemia, 11 who had no evidence of infiltration of the optic nerve or other ocular tissues, died within 28 months from the onset of leukaemia ( the identification of ocular manifestations. Five of these 13 patients, who presented with retinal haemorrhages or vascular changes alone, died within 12 months of identification of these ocular manifestations (Table 6 ). Ten ofthose 13 patients presented with retinal or vitreous haemorrhages at the time-ofbone marrow relapse not at the time of the initial induction treatment. All of these patients died within 9 months after developing With current sophisticated treatment regimens, this form of leukaemia has a cure rate greater than 60%. The predominance of acute lymphoblastic leukaemia in children and its excellent prognosis is the major reason for the difference in survival rate between childhood and adult leukaemia. Many patients, however, still suffer from relapse and are unlikely to achieve a complete cure. The presence of ophthalmic findings in childhood leukaemia is well known. Since modern chemotherapy was introduced, however, very few attempts have been made to relate the prognosis of the disease to ophthalmic manifestations.
In 1976, Ridgway et al' reported that 80% of children died within 10 months following ocular complications in acute leukaemia. In 1989, Lo Curto et al'0 reported that six of 38 patients with leukaemic ophthalmopathy achieved continuing complete remission. These two studies, however, did not indicate the prognosis, because the observation period was short or unclear.
The present study revealed that 96-4% (27/28) of children with acute leukaemia died within 28 months from the onset of ocular manifestations. Accordingly, this suggests that there is very little possibility for leukaemic patients with ocular manifestations to achieve complete cure even with modern treatment methods. One patient, however, is still alive. Lo Curto et al'°reported on the potential of long term complete remission (more than 78 months) in patients with isolated leukaemic ophthalmopathy. These facts may suggest that there is a possibility for patients with ophthalmic involvement to achieve a cure. An aggressive treatment to the eye, therefore, is recommended, not only to protect vision but also to attain a long term remission. We expect that today's more sophisticated treatment may improve the prognosis of patients with ophthalmic manifestations. Qavdar et all3 have reported that an ocular manifestation was asssociated with a poor prognosis. They reported that the mean survival rate in patients with acute myeloblastic leukaemic and orbito-ocular granulocytic sarcoma was significantly lower (8-7 months) than in those without orbito-ocular granulocytic sarcoma (28-6 months) after similar treatment. In the present study, the survival periods of the patients with extramedullary infiltration such as anterior segment uveal infiltration or orbital infiltration were extremely low. These facts suggest that extramedullary infiltration other than central nervous system leukaemic cell infiltration may influence the prognosis of acute non-lymphoblastic leukaemia.
Among ophthalmic manifestations, optic nerve infiltration is thought to be a partial presentation of central nervous system leukaemia. Although both optic nerve infiltration and the neuro-ophthalmic sign of central nervous system leukaemia have the same pathogenesis, in our patients these two disorders had quite different prognoses. The average survival period for patients with optic nerve infiltration was 50 8 months from the onset of leukaemia, and 60% of patients survived more than 5 years. In contrast the" average survival period for patients with the neuro-ophthalmic signs of central nervous system leukaemia without any other ocular tissue infiltration was 25-4 months from the onset of leukaemia, and the 5 year survival rate was only 9 1% (Table 7) . These results suggest that although both processes have the same pathogenesis, neuro-ophthalmic complications may represent a more advanced process, or greater systemic involvement than optic nerve infiltration.
Patients with neuro-ophthalmic signs of central nervous system leukaemia and patients with retinal or vitreous haemorrhages at the time of relapse died within a very short period (average of 4 1 and 3-1 months respectively). These two ocular manifestations, when identified in either central nervous system relapse or bone marrow relapse, suggested a very poor prognosis. The patients who presented with these findings at the time of the initial diagnosis survived longer. This reflects the fact that the remission rate at the time ofrelapse is lower than the rate at initial induction therapy. This may be related to the tolerance of antileukaemic agents.
This study demonstrated that the presence of ocular involvement with a poor prognostic sign in acute childhood leukaemia. The prognosis, however, was related to risk factors such as central nervous system leukaemia or bone marrow relapse. Some ophthalmic manifestations such as neuro-ophthalmic signs of central nervous system leukaemia, or retinal haemorrhages may be poor prognostic signs if they are seen in the relapse period. Ophthalmic examination in the relapse period, therefore, may be of some value in predicting survival.
